Drug name - Sorilux
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8629128 | MAYNE PHARMA | Vitamin formulation |
May, 2026
(3 years from now) | |
| US8263580 | MAYNE PHARMA | Vitamin formulation |
May, 2028
(5 years from now) | |
Drugs and Companies using CALCIPOTRIENE ingredient
Treatment: Use of a calcipotriene containing foam for the treatment of psoriasis; use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 18 years and older; use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 4 years and older; Use of a calcipotriene containing foam for the treatment of psoriasis; use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 4 years and older
Dosage: AEROSOL, FOAM;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.005% | AEROSOL, FOAM;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.